AAM Sees ‘Red Flag’ In IQVIA Biosimilars Report
US Association’s Biosimilars Council Cautions Over Long-Term Market Sustainability
Executive Summary
While the latest IQVIA data points to accelerated uptake of US biosimilars over the next five years, with associated increases in spending and savings, local off-patent industry association the AAM says the report raises a “red flag” over long-term market sustainability.